Publicaciones en colaboración con investigadores/as de Umeå University (15)

2022

  1. Clinical trials in pediatric ALS: a TRICALS feasibility study

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 23, Núm. 7-8, pp. 481-488

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2018

  1. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

    Neuron, Vol. 97, Núm. 6, pp. 1268-1283.e6

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Nature Genetics, Vol. 48, Núm. 9, pp. 1037-1042

2014

  1. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis

    Angewandte Chemie - International Edition, Vol. 53, Núm. 50, pp. 13765-13770

  2. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3751-3762

2012

  1. Structure-activity relationship of a new series of reversible dual monoacylglycerol lipase/fatty acid amide hydrolase inhibitors

    Journal of Medicinal Chemistry, Vol. 55, Núm. 2, pp. 824-836

2011

  1. New strategies in the development of antidepressants: Towards the modulation of neuroplasticity pathways

    Current Pharmaceutical Design, Vol. 17, Núm. 5, pp. 521-533

2007

  1. Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis - Comparison with effects upon fatty acid amide hydrolase

    Journal of Medicinal Chemistry, Vol. 50, Núm. 20, pp. 5012-5023

2006

  1. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations

    Journal of Neurochemistry, Vol. 99, Núm. 2, pp. 677-688

2003

  1. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

    European Journal of Medicinal Chemistry

  2. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase

    Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 1512-1522

  3. Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Núm. 3, pp. 225-231